Greg Destefano News Today

All week long Al Jazeera America is showcasing a selection of your stories. They include some of the most important issues weve covered on this channel for you, and there are few issues that matter more to my team and me than americas shrinking middle class. Ive explained the brutal economic headwinds blasting middle income americans. Those changes include technology, stagnant changes, the Housing Market collapse and a Great Recession that left many workers unemployed or earning a lot less than ...

If i cant figure out a way to access some of that wealth, then shame on me. All week long Al Jazeera America is showcasing a selection of your stories. They include some of the most important issues weve covered on this channel for you, and there are few issues that matter more to my team and me than americas shrinking middle class. Ive explained the brutal economic headwinds blasting middle income americans. Those changes include technology, stagnant changes, the Housing Market collapse and a G...

All week long Al Jazeera America is showcasing a selection of your stories. They include some of the most important issues weve covered on this channel for you, and there are few issues that matter more to my team and me than americas shrinking middle class. Ive explained the brutal economic headwinds blasting middle income americans. Those changes include technology, stagnant changes, the Housing Market collapse and a Great Recession that left many workers unemployed or earning a lot less than ...

A cancer treatment drug shortage is forcing Cook County Health doctors to make tough calls, and Sen. Dick Durbin wants changes.

There is currently a shortage of several cancer drugs across the United States and it means some patients are unable to receive life-saving treatment.

Chris Rogers/Getty Images(NEW YORK) -- Just six weeks ago, Greg DeStefano began a new chemotherapy combination. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors were hopeful the medication would treat the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his doctor and was told one of the three drugs he was receiving -- carboplatin -- was under a global shortage and because of th...

Chris Rogers/Getty Images(NEW YORK) -- Just six weeks ago, Greg DeStefano began a new chemotherapy combination. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors were hopeful the medication would treat the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his doctor and was told one of the three drugs he was receiving -- carboplatin -- was under a global shortage and because of th...

Chris Rogers/Getty Images(NEW YORK) -- Just six weeks ago, Greg DeStefano began a new chemotherapy combination. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors were hopeful the medication would treat the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his doctor and was told one of the three drugs he was receiving -- carboplatin -- was under a global shortage and because of th...

Chris Rogers/Getty Images(NEW YORK) -- Just six weeks ago, Greg DeStefano began a new chemotherapy combination. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors were hopeful the medication would treat the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his doctor and was told one of the three drugs he was receiving -- carboplatin -- was under a global shortage and because of th...

Chris Rogers/Getty Images(NEW YORK) -- Just six weeks ago, Greg DeStefano began a new chemotherapy combination. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors were hopeful the medication would treat the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his doctor and was told one of the three drugs he was receiving -- carboplatin -- was under a global shortage and because of th...